| HOME >> BIOLOGY >> TECHNOLOGY |
A step change in research relating to plasma nanoscience is needed for the world to overcome the challenge of sufficient energy creation and storage, says a leading scientist from CSIRO Materials Science and Engineering and the University of Sydney, Australia.
Professor Kostya (Ken) Ostrikov of the Plasma Nanoscience Centre Australia, CSIRO Materials Science and Engineering, has highlighted, in IOP Publishing's Journal of Physics D: Applied Physics, the unique potential of plasma nanoscience to control energy and matter at fundamental levels to produce cost-effective, environmentally and human health friendly nanoscale materials for applications in virtually any area of human activity.
Professor Ostrikov is a pioneer in the field of plasma nanoscience, and was awarded the Australian Future Fellowship (2011) of the Australian Research Council, Walter Boas Medal of the Australian Institute of Physics (2010), Pawsey Medal of the Australian Academy of Sciences (2008), and CEO Science Leader Fellowship and Award of CSIRO (2008) on top of gaining seven other prestigious fellowships and eight honorary and visiting professorships in six different countries.
He said: "We can find the best, most suitable plasmas and processes for virtually any application-specific nanomaterials using plasma nanoscience knowledge.
"The terms 'best' and 'most-suitable' have many dimensions including quality, yield, cost, environment and human friendliness, and most recently, energy efficiency."
Plasma nanoscience involves the use of plasma an ionised gas at temperatures from just a few to tens of thousands Kelvin as a tool to create and process very small (nano) materials for use in energy conversion, electronics, IT, health care, and numerous other applications that are critical for a sustainable future.
In particular, Ostrikov points out the ability of plasma to synthesise carbon nanotubes one of the most exciting ma
'/>"/>
| Contact: Joe Winters joseph.winters@iop.org 44-020-747-04815 Institute of Physics Source:Eurekalert |
Related biology technology :
1. PEAK Surgical Introduces PlasmaBlade(TM) Product Line Extensions for Use in General Surgery
2. Octapharma Names Dennis D. Curtin To Lead U.S. Plasma Operations
3. New White Paper Examines Advanced Mycoplasma Tests - How Real-Time PCR Analysis Helps Save Time and Money for Biopharmaceutical Manufacturers
4. Researchers prolong the plasma half-life of biopharmaceutical proteins
5. Norgen Biotek Launches 10 New Kits for the Isolation of High-Quality Circulating Nucleic Acids from Blood, Plasma and Serum
6. Painless plasma jets could replace dentists drill
7. Ruedi Waeger Receives the 2010 Robert W. Reilly Leadership Award from Plasma Protein Therapeutics Association
8. PPTA Urges CMS for Appropriate Hospital Outpatient Reimbursement for Plasma Protein Therapies
9. First Duplex Test for Parvovirus B19 and Hepatitis A Virus Increases Safety of Human Plasma and Plasma Products
10. Plasma Protein Therapies Not Suitable for Biosimilars
11. New Video on Plasma Donation Available
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |